Log In
Print
BCIQ
Print
Print this Print this
 

binimetinib (MEK162) (formerly ARRY-162)

Also known as: formerly ARRY-438162

  Manage Alerts
Collapse Summary General Information
Company Array BioPharma Inc.
DescriptionSmall molecule oral selective MEK1 and MEK2 inhibitor
Molecular Target MEK
Mechanism of ActionMEK inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$467.0M

0

$467.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today